dpp-4 inhibitors vs. glp-1 agonist GLP 1 Receptor Agonists and DPP 4 Mechanism of Action GLP-1 analogues and DPP-4 inhibitors
Description
sulfonylureas) may be indicated to avoid hypoglycaemia
35 As mentioned, in the absence of T2DM, nearly all glucose filtered through the glomeruli is reabsorbed via SGLTs
Central administration of GLP-1 and GIP decreases feeding in mice
Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit
It was developed by Sanofi Aventis under a license from Zealand Pharma
